277 related articles for article (PubMed ID: 3098471)
1. Differential expression and regulation of MHC products in the endocrine and exocrine cells of the human pancreas.
Pujol-Borrell R; Todd I; Doshi M; Gray D; Feldmann M; Bottazzo GF
Clin Exp Immunol; 1986 Jul; 65(1):128-39. PubMed ID: 3098471
[TBL] [Abstract][Full Text] [Related]
2. Mononuclear cell infiltration and its relation to the expression of major histocompatibility complex antigens and adhesion molecules in pancreas biopsy specimens from newly diagnosed insulin-dependent diabetes mellitus patients.
Itoh N; Hanafusa T; Miyazaki A; Miyagawa J; Yamagata K; Yamamoto K; Waguri M; Imagawa A; Tamura S; Inada M
J Clin Invest; 1993 Nov; 92(5):2313-22. PubMed ID: 8227346
[TBL] [Abstract][Full Text] [Related]
3. HLA-DR synthesis induction and expression in HLA-DR-negative carcinoma cell lines of diverse origins by interferon-gamma but not by interferon-beta.
Shaw AR; Chan JK; Reid S; Seehafer J
J Natl Cancer Inst; 1985 Jun; 74(6):1261-8. PubMed ID: 3923246
[TBL] [Abstract][Full Text] [Related]
4. Nicotinamide and 3-aminobenzamide reduce interferon-gamma-induced class II MHC (HLA-DR and -DP) molecule expression on cultured human endothelial cells and fibroblasts.
Otsuka A; Hanafusa T; Miyagawa J; Kono N; Tarui S
Immunopharmacol Immunotoxicol; 1991; 13(3):263-80. PubMed ID: 1834724
[TBL] [Abstract][Full Text] [Related]
5. HLA class II induction in human islet cells by interferon-gamma plus tumour necrosis factor or lymphotoxin.
Pujol-Borrell R; Todd I; Doshi M; Bottazzo GF; Sutton R; Gray D; Adolf GR; Feldmann M
Nature; 1987 Mar 19-25; 326(6110):304-6. PubMed ID: 3102976
[TBL] [Abstract][Full Text] [Related]
6. C. L. Oakley lecture (1987). The pathogenesis of beta cell destruction in type I (insulin-dependent) diabetes mellitus.
Foulis AK
J Pathol; 1987 Jul; 152(3):141-8. PubMed ID: 3309229
[TBL] [Abstract][Full Text] [Related]
7. Inappropriate major histocompatibility complex class II expression by thyroid follicular cells in thyroid autoimmune disease and by pancreatic beta cells in type I diabetes.
Pujol-Borrell R; Todd I; Londei M; Foulis A; Feldmann M; Bottazzo GF
Mol Biol Med; 1986 Apr; 3(2):159-65. PubMed ID: 3090400
[TBL] [Abstract][Full Text] [Related]
8. Induction of MHC class II molecules HLA-DR, -DP and -DQ and ICAM 1 in human podocytes by gamma-interferon.
Baudeau C; Delarue F; Hé CJ; Nguyen G; Adida C; Peraldi MN; Sraer JD; Rondeau E
Exp Nephrol; 1994; 2(5):306-12. PubMed ID: 7812737
[TBL] [Abstract][Full Text] [Related]
9. Evidence for Induced Expression of HLA Class II on Human Islets: Possible Mechanism for HLA Sensitization in Transplant Recipients.
Jackson AM; Connolly JE; Matsumoto S; Noguchi H; Onaca N; Levy MF; Naziruddin B
Transplantation; 2009 Feb; 87(4):500-6. PubMed ID: 19307785
[TBL] [Abstract][Full Text] [Related]
10. Interferon-gamma modulates HLA class II antigen expression on cultured human thymic epithelial cells.
Berrih S; Arenzana-Seisdedos F; Cohen S; Devos R; Charron D; Virelizier JL
J Immunol; 1985 Aug; 135(2):1165-71. PubMed ID: 3925000
[TBL] [Abstract][Full Text] [Related]
11. Regulation of HLA-DR and invariant chain expression by human peripheral blood mononuclear cells with lead, interferon-gamma, or interleukin-4.
Guo TL; Mudzinski SP; Lawrence DA
Cell Immunol; 1996 Jul; 171(1):1-9. PubMed ID: 8660831
[TBL] [Abstract][Full Text] [Related]
12. Interferon-gamma induces HLA-DR expression by thyroid epithelium.
Todd I; Pujol-Borrell R; Hammond LJ; Bottazzo GF; Feldmann M
Clin Exp Immunol; 1985 Aug; 61(2):265-73. PubMed ID: 3930110
[TBL] [Abstract][Full Text] [Related]
13. T-splenocytes from non-obese diabetic mice binding to xenogeneic pancreatic beta-cells in vitro. Implication of the alpha/beta T-cell receptor and of major histocompatibility complex class II molecules from target cells.
Martignat L; Feve B; Ouary M; Pogu S; Charbonnel B; Saï P
J Autoimmun; 1993 Dec; 6(6):753-69. PubMed ID: 8155255
[TBL] [Abstract][Full Text] [Related]
14. In situ characterization of autoimmune phenomena and expression of HLA molecules in the pancreas in diabetic insulitis.
Bottazzo GF; Dean BM; McNally JM; MacKay EH; Swift PG; Gamble DR
N Engl J Med; 1985 Aug; 313(6):353-60. PubMed ID: 3159965
[TBL] [Abstract][Full Text] [Related]
15. Regulation of class II MHC molecules on human endothelial cells. Effects of IFN and dexamethasone.
Manyak CL; Tse H; Fischer P; Coker L; Sigal NH; Koo GC
J Immunol; 1988 Jun; 140(11):3817-21. PubMed ID: 2453556
[TBL] [Abstract][Full Text] [Related]
16. Effects of human recombinant alpha 2 arg-interferon and gamma-interferon on human breast cancer cell lines: dissociation of antiproliferative activity and induction of HLA-DR antigen expression.
Gastl G; Marth C; Leiter E; Gattringer C; Mayer I; Daxenbichler G; Flener R; Huber C
Cancer Res; 1985 Jul; 45(7):2957-61. PubMed ID: 3924395
[TBL] [Abstract][Full Text] [Related]
17. Cloned human interferon-gamma, but not interferon-beta or -alpha, induces expression of HLA-DR determinants by fetal monocytes and myeloid leukemic cell lines.
Kelley VE; Fiers W; Strom TB
J Immunol; 1984 Jan; 132(1):240-5. PubMed ID: 6418799
[TBL] [Abstract][Full Text] [Related]
18. Human fetal islet response to interferon gamma.
Ruhland B; Walker L; Peterson CM
Ann Clin Lab Sci; 1994; 24(4):312-23. PubMed ID: 7944269
[TBL] [Abstract][Full Text] [Related]
19. The role of interferon regulatory factor-1 in cytokine-induced mRNA expression and cell death in murine pancreatic beta-cells.
Pavlovic D; Chen MC; Gysemans CA; Mathieu C; Eizirik DL
Eur Cytokine Netw; 1999 Sep; 10(3):403-12. PubMed ID: 10477397
[TBL] [Abstract][Full Text] [Related]
20. Differential presentation of HLA-DR, DQ, and DP restriction elements by interferon-gamma-treated dermal fibroblasts.
Maurer DH; Hanke JH; Mickelson E; Rich RR; Pollack MS
J Immunol; 1987 Aug; 139(3):715-23. PubMed ID: 3110281
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
